Holli K - Search Results

1

Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: a prospective randomized trial.

Joensuu H, Holli K, Heikkinen M, Suonio E, Aro AR, Hietanen P, Huovinen R. Joensuu H, et al. Among authors: holli k. J Clin Oncol. 1998 Dec;16(12):3720-30. doi: 10.1200/JCO.1998.16.12.3720. J Clin Oncol. 1998. PMID: 9850014 Clinical Trial.

2

Radiotherapy after segmental resection of breast cancer with favorable prognostic features: 12-year follow-up results of a randomized trial.

Holli K, Hietanen P, Saaristo R, Huhtala H, Hakama M, Joensuu H. Holli K, et al. J Clin Oncol. 2009 Feb 20;27(6):927-32. doi: 10.1200/JCO.2008.19.7129. Epub 2008 Dec 29. J Clin Oncol. 2009. PMID: 19114687 Clinical Trial.

3

Safety and efficacy results of a randomized trial comparing adjuvant toremifene and tamoxifen in postmenopausal patients with node-positive breast cancer. Finnish Breast Cancer Group.

Holli K, Valavaara R, Blanco G, Kataja V, Hietanen P, Flander M, Pukkala E, Joensuu H. Holli K, et al. J Clin Oncol. 2000 Oct 15;18(20):3487-94. doi: 10.1200/JCO.2000.18.20.3487. J Clin Oncol. 2000. PMID: 11032589 Clinical Trial.

4

A short communication course for physicians improves the quality of patient information in a clinical trial.

Hietanen PS, Aro AR, Holli KA, Schreck M, Peura A, Joensuu HT. Hietanen PS, et al. Acta Oncol. 2007;46(1):42-8. doi: 10.1080/02841860600849067. Acta Oncol. 2007. PMID: 17438704

5

Information and communication in the context of a clinical trial.

Hietanen P, Aro AR, Holli K, Absetz P. Hietanen P, et al. Among authors: holli k. Eur J Cancer. 2000 Oct;36(16):2096-104. doi: 10.1016/s0959-8049(00)00191-x. Eur J Cancer. 2000. PMID: 11044647 Clinical Trial.

6

Serum lipid levels during and after adjuvant toremifene or tamoxifen therapy for breast cancer.

Joensuu H, Holli K, Oksanen H, Valavaara R. Joensuu H, et al. Among authors: holli k. Breast Cancer Res Treat. 2000 Oct;63(3):225-34. doi: 10.1023/a:1006465732143. Breast Cancer Res Treat. 2000. PMID: 11110056 Clinical Trial.

7

Omission of histologic grading from clinical decision making may result in overuse of adjuvant therapies in breast cancer: results from a nationwide study.

Lundin J, Lundin M, Holli K, Kataja V, Elomaa L, Pylkkänen L, Turpeenniemi-Hujanen T, Joensuu H. Lundin J, et al. Among authors: holli k. J Clin Oncol. 2001 Jan 1;19(1):28-36. doi: 10.1200/JCO.2001.19.1.28. J Clin Oncol. 2001. PMID: 11134192

8

Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study.

Holli K, Saaristo R, Isola J, Joensuu H, Hakama M. Holli K, et al. Br J Cancer. 2001 Jan;84(2):164-9. doi: 10.1054/bjoc.2000.1571. Br J Cancer. 2001. PMID: 11161371 Free PMC article. Clinical Trial.

9

Postoperative PINP in serum reflects metastatic potential and poor survival in node-positive breast cancer.

Jukkola A, Bloigu R, Holli K, Joensuu H, Valavaara R, Risteli J, Blanco G. Jukkola A, et al. Among authors: holli k. Anticancer Res. 2001 Jul-Aug;21(4B):2873-6. Anticancer Res. 2001. PMID: 11712779

10

Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study.

Joensuu H, Isola J, Lundin M, Salminen T, Holli K, Kataja V, Pylkkänen L, Turpeenniemi-Hujanen T, von Smitten K, Lundin J. Joensuu H, et al. Among authors: holli k. Clin Cancer Res. 2003 Mar;9(3):923-30. Clin Cancer Res. 2003. PMID: 12631589

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters